The Walkers’ team of partner Kate Storey, senior counsel Stephen Ozanne and associate Adam Pickering have represented Chrystal Capital Partners LLP in relation to the registration of Guernsey’s first healthcare cannabinoid investment fund. The fund is called Verdite Capital Fund I L.P. which was registered by the GFSC on 29 July 2020.
Verdite Capital Fund I L.P. will focus on investments in businesses across the legal cannabinoid market worldwide, particularly in North America and Europe. Elysium Fund Management Limited are the designated administrator and Centaur Fund Services Limited in Dublin are the sub-administrator.
The regulatory approval for the fund demonstrates that Guernsey is a leading international financial centre that can provide innovative solutions for novel investment products in an internationally recognised and well regulated jurisdiction.
